Drug intelligence / Profile preview

volbella + juvederm ultra xc

Development stage
Unknown
Lead developer
Allergan
Modality
Recombinant Proteins and Enzymes
Administration
Intradermal, Subcutaneous
01

Overview

This is a combination of two injectable dermal fillers from the Juvéderm product line—Juvéderm Volbella XC and Juvéderm Ultra XC. Both are hyaluronic acid-based gels formulated with lidocaine for local anesthesia. - **Juvéderm Volbella XC** is designed for lip augmentation, correction of perioral lines (lipstick lines), and improvement of infraorbital hollowing (undereye hollows). It uses VYCROSS technology to create a smooth gel that integrates well into tissue, providing subtle volume and smoothing effects that can last up to one year[2][3][4][5][6]. - **Juvéderm Ultra XC** is indicated for injection into the lips and perioral area for lip augmentation in adults over 21 years old. It provides more robust volumization compared to Volbella, making it suitable for patients seeking fuller lips or correction of moderate facial wrinkles[2][5]. Both products are FDA-approved as temporary fillers; they work by adding volume through crosslinked hyaluronic acid, which attracts water molecules and integrates into the skin matrix. Lidocaine reduces discomfort during injection.

Brand names
Juvederm Volbella XC
Other names
Volbella + Juvederm Ultra XC

Beyond the preview

Go deeper on volbella + juvederm ultra xc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on volbella + juvederm ultra xc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call